Congenital nasolacrimal duct obstruction continues trend for spontaneous resolution beyond first year of life.


Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
08 2020
Historique:
received: 30 07 2019
revised: 25 09 2019
accepted: 21 10 2019
pubmed: 5 11 2019
medline: 16 1 2021
entrez: 3 11 2019
Statut: ppublish

Résumé

To investigate spontaneous resolution of congenital nasolacrimal duct obstruction (CNLDO) beyond 12 months of age in Japanese infants. Retrospective, observational case series. We retrospectively reviewed the clinical records of patients diagnosed with CNLDO beyond 12 months of age at Kyoto Prefectural University Hospital, Kyoto, Japan. This study involved 155 cases of CNLDO in 133 Japanese infants diagnosed with CNLDO. All patients chose intervention with either dacryoendoscopic guided probing and stenting or conservative management. The proportion and age of patients who had spontaneous CLNDO resolution were analysed. The patients were divided into two groups: (1) 62 patients with 70 obstructed nasolacrimal ducts (45%) in whom spontaneous resolution occurred and (2) 71 patients with 85 obstructed nasolacrimal ducts (55%) who underwent dacryoendoscopic guided probing and stenting. The mean age of spontaneous resolution was 17.8±5.3 months (range: 12.0-35.4 months). Dacryoendoscopic guided probing and stenting were successful in 83/85 (97.6%) of cases. Spontaneous resolution of CNLDO can occur in 45% of infants over the age of 12 months. Dacryoendoscopic guided stenting also has high success rates in this patient group, and both treatment options can be proposed to caregivers.

Identifiants

pubmed: 31676597
pii: bjophthalmol-2019-314980
doi: 10.1136/bjophthalmol-2019-314980
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1161-1163

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Tomomichi Nakayama (T)

Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Akihide Watanabe (A)

Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan awatanab@koto.kpu-m.ac.jp.

Saul Rajak (S)

The Sussex Eye Hospital, Brighton, UK.

Yukito Yamanaka (Y)

Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Chie Sotozono (C)

Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH